Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate–binding region
McKenna Kelly(Boston Children's Hospital), Annapurna Poduri(Broad Institute), Christina Hung(Boston Children's Hospital), Saima Kayani(The University of Texas Southwestern Medical Center), Edward Yang(Insper), Ivana Mihalek(Boston Children's Hospital), Jeff L. Waugh(Children's Medical Center), Anne Rochtus(Boston Children's Hospital), Ingrid E. Scheffer(The University of Melbourne), Irina Anselm(Boston Children's Hospital), Heather E. Olson(Boston Children's Hospital), Erika Axeen(Boston Children's Hospital), Molly Snyder(Medical City Children's Hospital), David A. Sweetser(Massachusetts General Hospital), Meredith Park(Boston Children's Hospital), Olaf A. Bodamer(Broad Institute), Sophie Calvert(Children's Health Queensland Hospital and Health Service), Eduardo Pérez‐Palma(Universidad del Desarrollo), Lauren C. Briere(Duke Medical Center), Frances A. High(Harvard University), Marie Gramm, Lindsay C. Swanson(Boston Children's Hospital), Dennis Lal(Broad Institute)
Cited by 76
Related Papers
ILAE Official Report: A practical clinical definition of epilepsy
|Epilepsia|2014|5.9k
<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology
|Epilepsia|2017|4.9k
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535